CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: RIVastigmine In Vascular cognitivE Impairment [Phase 4]
Summary
A Phase 4 trial evaluating rivastigmine for vascular cognitive impairment has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Singapore General Hospital | Conditions: Cognitive Impairment | Phase 4 | Status: COMPLETED